Home Featured Page 169

Featured

Latest

The Psychedelic Writers Guild’s Denver Mixer

The Mushroom Cure – Special Live Filming

Pα+ Psychedelic Bulletin #222: Unpacking EPIsoDE; Meta-Analysis Says Psychedelics No Better than Traditional Antidepressants; Usona’s First Patent Application Publishes

BREAKING: Otsuka to Acquire Methylone Drug Developer Transcend in $1.23B Deal

Esme Dark – Psychedelics, Somatics and the Shadow

Small Pharma Reports Fiscal First Quarter 2023 Highlights

FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT

Numinus Wellness Inc. Reports Q3 2022 Results

Psychedelic Bulletin #111 – Psychedelics on Netflix; House Adopts 2 Psychedelic...

MDMA: Rolling from Counterculture to the Clinic Counter

PT337 – Lauren Katalinich & Anya Oleksiuk – The Psychedelic Society:...

Silo Pharma Announces Positive Results in Subcutaneous Delivery of its Novel...

Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And...

PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for...

FILAMENT HEALTH ISSUED THIRD PATENT BY UNITED STATES PATENT AND TRADEMARK...

EDITOR PICKS

The Psychedelic Writers Guild’s Denver Mixer

The Mushroom Cure – Special Live Filming

Pα+ Psychedelic Bulletin #222: Unpacking EPIsoDE; Meta-Analysis Says Psychedelics No Better...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Psychedelic Writers Guild’s Denver Mixer

The Mushroom Cure – Special Live Filming

Pα+ Psychedelic Bulletin #222: Unpacking EPIsoDE; Meta-Analysis Says Psychedelics No Better than Traditional Antidepressants; Usona’s First Patent Application Publishes

BREAKING: Otsuka to Acquire Methylone Drug Developer Transcend in $1.23B Deal

Esme Dark – Psychedelics, Somatics and the Shadow

Small Pharma Reports Fiscal First Quarter 2023 Highlights

FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT

Numinus Wellness Inc. Reports Q3 2022 Results

Psychedelic Bulletin #111 – Psychedelics on Netflix; House Adopts 2 Psychedelic...

MDMA: Rolling from Counterculture to the Clinic Counter

PT337 – Lauren Katalinich & Anya Oleksiuk – The Psychedelic Society:...

Silo Pharma Announces Positive Results in Subcutaneous Delivery of its Novel...

Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And...

PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for...

FILAMENT HEALTH ISSUED THIRD PATENT BY UNITED STATES PATENT AND TRADEMARK...

EDITOR PICKS

The Psychedelic Writers Guild’s Denver Mixer

The Mushroom Cure – Special Live Filming

Pα+ Psychedelic Bulletin #222: Unpacking EPIsoDE; Meta-Analysis Says Psychedelics No Better...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY